September 4, 2007 - Analysis of clinical trials showed the Cypher Sirolimus-eluting coronary stent was associated with ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
August 28, 2007 – The FDA Advisory Panel will review the Premarket Approval (PMA) application for Endeavor Drug Eluting ...
August 22, 2007 - Medtronic, Inc. announced it has been informed by the FDA that an Advisory Panel will review the ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 21, 2007 - University of Arkansas researchers have discovered a simple, inexpensive way to create a ...
August 20, 2007 - Cardiatis, SA announced that it has completed recruitment of patients into its first European ...
August 15, 2007 - InspireMD announced today receipt of orders for its MGuard Coronary stents from key markets in Western ...
August 13, 2007 – A study published in the Journal of the American College of Cardiology showed that when ...
August 9, 2007 - Compared with their counterparts a decade ago, today's heart attack patients are receiving ...
August 8, 2007 – Emageon Inc. reported financial results for its second quarter ended June 30, 2007, reflecting net ...
August 8, 2007 - A U.S. District Court judge enforced a settlement this week between Abbott Laboratories Inc. and ...
August 7, 2007 - The American College of Cardiology and the American Heart Association have jointly released ...
July 20, 2007 – Despite forecasts by analysts at Thomson Financial that Boston Scientific Corp. would earn $150 million ...
July 19, 2007 – Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...
Source: Wall Street Journal Online
July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...
July 17, 2007 - Boston Scientific Corp. today announced the implantation of its TAXUS Petal Bifurcation Paclitaxel ...